Graf Akcie REPH (Recro Pharma Inc). Diskuze k akciím REPH. Aktuální informace REPH.

Základní informace o společnosti Recro Pharma Inc (Akcie REPH)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 57.06M
Hodnota podniku (EV) N/A
Tržby 64.02M
EBITDA N/A
Zisk -19.32
Růst v tržbách Q/Q 16.07 %
Růst v tržbách Y/Y -20.17 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 0.07
EV/Sales 2.04
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 0.89
P/FCF 620.27
Price/Book -4.05
Účetní hodnota na akcii -0.46
Hotovost na akcii 0.78
FCF vůči ceně 0.16 %
Počet zaměstnanců 185
Tržba na zaměstnance 346.054k
Profit margin -41.36 %
Operating margin -9.02 %
Gross margin 18.59 %
EBIT margin -3.79 %
EBITDA margin 46.28 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -112.00 %
EPS - Očekávaný růst příští rok 0.00 %
Return on assets -18.23 %
Return on equity 669.75 %
ROIC -7.80 %
ROCE -2.07 %
Dluhy/Equity -8.33
Čistý dluh/EBITDA 10.91
Current ratio 14.29
Quick Ratio 12.81
Volatilita 5.90
Beta 1.70
RSI 35.14
Cílová cena analytiků 7
Známka akcie (dle analytiků) N/A
Insider ownership 7.26 %
Institutional ownership 72.87 %
Počet akcií 46.615M
Procento shortovaných akcií 1.27 %
Short ratio 1.87 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie REPH

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$99.219$77.347$71.834$69.337$51.952--
Cost Of Goods Sold$50.981$43.16$38.193$37.152$28.054--
Gross Profit$48.238$34.187$33.641$32.185$23.898--
Research And Development Expenses-$4.402$4.46$33.278$12.281$7.874$0.544
SG&A Expenses$19.909$14.437$14.324$12.742$13.017$3.998$0.546
Other Operating Income Or Expenses$-2.116$-0.284$-0.009$-9.355$-3.686--
Operating Expenses$75.589$64.866$59.569$95.11$58.922$11.872$1.09
Operating Income$23.63$12.481$12.265$-25.773$-6.97$-11.872$-1.09
Total Non-Operating Income/Expense$-19.005$-8.113$-11.665$-5.539$-5.548$-4.262$-0.868
Pre-Tax Income$4.625$4.368$0.6$-31.312$-12.518$-16.134$-1.958
Income Taxes-$17.436$7.317$-1.107$-15.551--
Income After Taxes$4.625$-13.068$-6.717$-30.205$3.033$-16.134$-1.958
Other Income-------
Income From Continuous Operations$4.625$-13.068$-6.717$-30.205$3.033$-16.134$-1.958
Income From Discontinued Operations$-23.255$-66.655$-43.365----
Net Income$-18.63$-79.723$-50.082$-30.205$3.033$-17.404$-2.398
EBITDA$32.03$19.936$19.641$-18.197$-0.966$-11.872$-1.088
EBIT$23.63$12.481$12.265$-25.773$-6.97$-11.872$-1.09
Basic Shares Outstanding22201911860
Shares Outstanding24201911960
Basic EPS$-0.83$-3.90$-2.63$-2.82$0.36$-2.79$-15.41
EPS - Earnings Per Share$-0.79$-3.90$-2.63$-2.82$0.21$-2.79$-15.41
# 2020 2019 2018 2017 2016 2015
Current Ratio9.27682.45061.7495.21234.076714.0899
Long-term Debt / Capital1.06481.43580.65010.23630.3849-
Debt/Equity Ratio-16.4361-3.29451.85790.34060.7375-
Gross Margin48.617744.199546.831646.418246.0002-
Operating Margin23.81616.136417.0741-37.1706-13.4162-
EBIT Margin23.81616.136417.0741-37.1706-13.4162-
EBITDA Margin32.282125.774827.3422-26.2443-1.8594-
Pre-Tax Profit Margin4.66145.64730.8353-45.1592-24.0953-
Net Profit Margin-18.7767-103.0719-69.7191-43.56265.8381-
Asset Turnover0.89820.49740.38570.37890.3746-
Inventory Turnover Ratio3.38254.0343.88184.24793.1234-
Receiveable Turnover6.89556.01177.41636.666.055-
Days Sales In Receivables52.933360.714649.216154.80560.2806-
ROE - Return On Equity-68.906567.0154-23.2841-42.17817.5167-85.2388
Return On Tangible Equity-32.31144.022253.9605-108.9097-49.6238-85.2388
ROA - Return On Assets4.1871-8.4042-3.6069-16.50572.1868-79.1892
ROI - Return On Investment4.464-29.2068-8.1472-32.21354.6239-85.2388
Book Value Per Share-0.2879-0.89451.50823.76064.37452.4556
Operating Cash Flow Per Share0.1486-0.46161.2988-1.26532.70863.5063
Free Cash Flow Per Share0.147-0.52991.3671-1.34152.43313.5063